Kezar Life Sciences Inc

NASDAQ:KZR  
5.55
+0.06 (+1.09%)
Earnings Announcements

Kezar Life Sciences Reports Q1 2022 Results

Published: 05/12/2022 20:59 GMT
Kezar Life Sciences Inc (KZR) - Kezar Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update.
Qtrly Net Loss per Common Share, Basic and Diluted$0.26.
Q1 Earnings per Share View $-0.28 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.32

More details on our Analysts Page.